Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Synopsys

Synopsys Surges After Topping Targets, Guiding Well Above Views

Synopsys, a maker of semiconductor design software, surged Thursday after it handily beat analyst estimates for its fiscal second quarter.

Investors Business Daily

Adobe vs. Synopsys: Which Growth Stock is a Better Buy?

Despite aggressive interest rate hikes expectations and other factors keeping the market volatile, the recovering labor market and substantial corporate profits have driven the performance of some quality growth stocks like Synopsys (SNPS) and Adobe (ADBE). But which of these two stocks is a better buy now? Read more to…

StockNews.com

Top-Ranked Synopsys Stock Moves Up A Notch

Synopsys shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

StockNews.com

IBD Screen Of The Day: Analysts Raise Profit Estimates On These Top Ranked Stocks

Semiconductor design and verification stock Synopsys has been displaying strong growth with a three-year EPS growth rate of 26%.

Investors Business Daily

Dow Jones Gains; Twitter Stock Explodes As Elon Musk Invests; Donald Trump SPAC Plummets

The Dow Jones gained. Twitter exploded on news Tesla CEO Elon Musk has bought shares. The Donald Trump SPAC plummeted.

Investors Business Daily

Synopsys Ranks No. 1 Among Software Makers

Synopsys sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

This Foreboding Sign Looms Over Synopsys's Chart

If history is any guide, there may be trouble ahead for shares of Synopsys (NASDAQ:SNPS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Synopsys: Q1 Earnings Insights

Synopsys (NASDAQ:SNPS) reported its Q1 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Synopsys beat estimated earnings by 1.27%, reporting an EPS of $2.4 versus an estimate of $2.37.

Benzinga

Synopsys Earnings Preview

Synopsys (NASDAQ:SNPS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Synopsys will report an earnings per share (EPS) of $2.37.

Benzinga

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.